These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3140409)

  • 21. Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction.
    Huber K; Rosc D; Resch I; Schuster E; Glogar DH; Kaindl F; Binder BR
    Thromb Haemost; 1988 Dec; 60(3):372-6. PubMed ID: 3149044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Decreased fibrinolytic capacity in coronary patients by increased plasminogen activator inhibitor activity].
    Ihnken K; Speiser W; Müller-Berghaus G; Beyersdorf F; Schlepper M; Satter P
    Helv Chir Acta; 1992 Jan; 58(4):503-8. PubMed ID: 1582860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibrinolysis and coagulation in patients with infectious disease and sepsis.
    Philippé J; Offner F; Declerck PJ; Leroux-Roels G; Vogelaers D; Baele G; Collen D
    Thromb Haemost; 1991 Mar; 65(3):291-5. PubMed ID: 1904655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasminogen activator inhibitor activity in bacterial infection.
    Páramo JA; Fernández Diaz FJ; Rocha E
    Thromb Haemost; 1988 Jun; 59(3):451-4. PubMed ID: 3142082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma Fibrinolysis Parameters in Smokers and Non-smokers of the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study.
    Delgado GE; Siekmeier R; Krämer BK; März W; Kleber ME
    Adv Exp Med Biol; 2015; 858():69-77. PubMed ID: 25786403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic synthesis and clearance of components of the fibrinolytic system in healthy volunteers and in patients with different stages of liver cirrhosis.
    Huber K; Kirchheimer JC; Korninger C; Binder BR
    Thromb Res; 1991 Jun; 62(5):491-500. PubMed ID: 1910213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Thromboembolic disease and anomalies of fibrinolysis].
    Juhan-Vague I; Aillaud MF; Valadier J; Alessi MC; Serradimigni A
    Ann Med Interne (Paris); 1986; 137(6):471-4. PubMed ID: 3101564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasminogen activators t-PA, u-PA and its inhibitor (PAI) in normal males and females.
    Koh SC; Yuen R; Viegas OA; Chua SE; Ng BL; Sen DK; Ratnam SS
    Thromb Haemost; 1991 Nov; 66(5):581-5. PubMed ID: 1803623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired fibrinolysis in obstructive jaundice--evidence from clinical and experimental studies.
    Colucci M; Altomare DF; Chetta G; Triggiani R; Cavallo LG; Semeraro N
    Thromb Haemost; 1988 Aug; 60(1):25-9. PubMed ID: 3142090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Tissue plasminogen activator (T-PA) and tissue plasminogen activator inhibitor (PAI-1) in patients after head injury].
    Beuth W; Kotschy M; Kasprzak HA; Rość D; Osiński P; Sniegocki M
    Neurol Neurochir Pol; 1996; 30(3):427-34. PubMed ID: 8965977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibrinolytic activity in peripheral atherosclerosis in the elderly.
    van der Bom JG; Bots ML; Haverkate F; Meyer P; Hofman A; Grobbee DE; Kluft C
    Thromb Haemost; 1999 Feb; 81(2):275-80. PubMed ID: 10064006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of chronic smoking on the fibrinolytic potential of plasma and platelets.
    Simpson AJ; Gray RS; Moore NR; Booth NA
    Br J Haematol; 1997 Apr; 97(1):208-13. PubMed ID: 9136967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombosis after hip replacement. Relationship to the fibrinolytic system.
    Eriksson BI; Eriksson E; Gyzander E; Teger-Nilsson AC; Risberg B
    Acta Orthop Scand; 1989 Apr; 60(2):159-63. PubMed ID: 2471386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal and hepatic handling of endogenous tissue-type plasminogen activator (t-PA) and its inhibitor in man.
    Brommer EJ; Derkx FH; Schalekamp MA; Dooijewaard G; vd Klaauw MM
    Thromb Haemost; 1988 Jun; 59(3):404-11. PubMed ID: 3142078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of baseline plasminogen activator inhibitor activity with patency of the infarct artery after thrombolytic therapy in acute myocardial infarction.
    Barbash GI; Hod H; Roth A; Miller HI; Rath S; Zahav YH; Modan M; Zivelin A; Laniado S; Seligsohn U
    Am J Cardiol; 1989 Dec; 64(19):1231-5. PubMed ID: 2511742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1).
    Angleton P; Chandler WL; Schmer G
    Circulation; 1989 Jan; 79(1):101-6. PubMed ID: 2491971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
    J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin, cortisol and catecholamines do not regulate circadian variations in fibrinolytic activity.
    Chandler WL; Mornin D; Whitten RO; Angleton P; Farin FM; Fritsche TR; Veith RC; Stratton JR
    Thromb Res; 1990 Apr; 58(1):1-12. PubMed ID: 2111589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma plasminogen activator inhibitor-1 in angina pectoris. Influence of plasma insulin and acute-phase response.
    Juhan-Vague I; Alessi MC; Joly P; Thirion X; Vague P; Declerck PJ; Serradimigni A; Collen D
    Arteriosclerosis; 1989; 9(3):362-7. PubMed ID: 2470343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of a plasminogen activator and its inhibitor in human mesangial cells.
    Lacave R; Rondeau E; Ochi S; Delarue F; Schleuning WD; Sraer JD
    Kidney Int; 1989 Mar; 35(3):806-11. PubMed ID: 2496257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.